Clinical Study

Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer

Table 2

Correlation matrix of imaging biomarkers and clinical parameters.

SUVmaxSUVmeanUVPMTVKtransmaxKtranskurKepmaxKepkuriAUCmaxiAUCkurADCminADCmeanADCkurPSAGS

SUVmaxCorrelation10.900.690.590.350.150.18−0.040.400.25−0.04−0.190.100.46−0.31
value<0.01<0.01<0.010.060.410.350.850.030.180.820.310.600.010.10
SUVmeanCorrelation10.560.420.190.06−0.02−0.190.280.250.09−0.300.140.39−0.33
value<0.010.020.300.760.920.310.130.170.640.100.470.030.07
UVPCorrelation10.980.370.310.340.300.510.45−0.41−0.310.370.760.16
value<0.010.040.090.060.11<0.010.010.020.090.04<0.010.40
MTVCorrelation10.390.250.410.400.510.48−0.47−0.280.400.750.25
value0.030.170.020.03<0.010.010.010.120.03<0.010.18
KtransmaxCorrelation110.800.550.600.47−0.240.020.370.180.04
value<0.01<0.01<0.01<0.010.010.200.930.040.340.83
KtranskurCorrelation10.740.710.340.780.01−0.090.300.100.25
value<0.01<0.010.07<0.010.950.640.100.580.17
KepmaxCorrelation10.800.500.47−0.31−0.040.210.150.21
value0.000.000.010.090.840.260.410.25
KepkurCorrelation10.320.47−0.26−0.110.240.200.41
value0.090.010.150.570.190.290.02
iAUCmaxCorrelation10.36−0.25−0.010.260.300.11
value0.0460.170.950.160.100.57
iAUCkurCorrelation1−0.08−0.350.300.330.36
value0.680.050.100.070.049
ADCminCorrelation10.14−0.08−0.36−0.33
value0.440.660.0460.07
ADCmeanCorrelation1−0.20−0.38−0.22
value0.280.040.23
ADCkurCorrelation10.230.35
value0.220.06
PSACorrelation10.17
value0.35
GSCorrelation1
value

Statistically significant by Spearman’s correlation method. PSA, prostate-specific antigen; GS, Gleason score.